2
|
Hassan A, Lawlis S, Landmann A, Ruiz-Elizalde A, Middleman A. Not just an upset stomach: gastric perforation in a patient with anorexia nervosa. Eat Weight Disord 2022; 27:1907-1911. [PMID: 34731455 DOI: 10.1007/s40519-021-01312-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Accepted: 09/20/2021] [Indexed: 10/19/2022] Open
Abstract
Gastric perforation in patients with anorexia nervosa is a rare entity associated with high morbidity and mortality [Norris in Int J Eat Disord 49:216-237, 2016]. In cases reported in the literature, the perforation was often preceded by a binge episode, and the subsequent clinical presentation was rapid and acutely deteriorating with a fatality rate as high as 80% [Norris in Int J Eat Disord 49:216-237, 2016, Pitre in J Med Case Rep 15:61, 2021]. We present a case of gastric perforation in the context of restrictive anorexia nervosa unique both for the absence of a premorbid binge episode as well as delayed clinical manifestations of medical distress, leading to abdominal compartment syndrome.Level IV Evidence obtained from multiple time series analysis such as case studies.
Collapse
Affiliation(s)
- Ahmad Hassan
- The University of Oklahoma, Oklahoma City, OK, USA.
| | | | | | | | | |
Collapse
|
3
|
Marshall A, Pickle S, Lawlis S. Transgender Medicine Curriculum: Integration Into an Organ System-Based Preclinical Program. MedEdPORTAL 2017; 13:10536. [PMID: 30800738 PMCID: PMC6342291 DOI: 10.15766/mep_2374-8265.10536] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/15/2016] [Accepted: 12/29/2016] [Indexed: 05/28/2023]
Abstract
INTRODUCTION There is a recognized and articulated need for health professionals to understand the definitions, health disparities, and medical management of transgender patients. This recognition comes organically from students requesting more information, and top-down from governing bodies such as the AAMC or the Liaison Committee on Medical Education. Surveys of North American medical schools indicate that training in transgender medicine (specifically, the process of transition) is infrequent and inadequate. One problem underlying this trend may be the lack of resources to help conceptualize and roll out a transgender medicine curriculum. METHODS Here, we report the integration of training in transgender medicine into the organ system-based course Endocrine-Reproduction. This transgender curriculum includes coverage of basic science, clinical management, ethics, and clinical skills. The curriculum leverages an already existing, health care disparity-focused curriculum but adds (1) a didactic component for dissemination and discussion of basic science principles applied to transgender patients and (2) a mock initial encounter between a physician and patient with gender dysphoria. RESULTS Following the first-time implementation of the transgender curriculum, students were surveyed, with a large majority reporting feeling more prepared to care for transgender patients. DISCUSSION We conclude that including a multidisciplinary transgender medicine curriculum in medical school advances the goal of creating safe, effective physicians by providing fundamental knowledge about an underserved population of patients, as well as exampled application of that knowledge.
Collapse
Affiliation(s)
- Aaron Marshall
- Assistant Professor and Endocrine-Reproduction Course Director, Department of Medical Education, University of Cincinnati College of Medicine
| | - Sarah Pickle
- Assistant Professor, Department of Family and Community Medicine, University of Cincinnati College of Medicine
| | - Shauna Lawlis
- Fellow, Division of Adolescent and Transition Medicine, Cincinnati Children's Hospital Medical Center
| |
Collapse
|
4
|
Toda N, Hao X, Ogawa Y, Oda K, Yu M, Fu Z, Chen Y, Kim Y, Lizarzaburu M, Lively S, Lawlis S, Murakoshi M, Nara F, Watanabe N, Reagan JD, Tian H, Fu A, Motani A, Liu Q, Lin YJ, Zhuang R, Xiong Y, Fan P, Medina J, Li L, Izumi M, Okuyama R, Shibuya S. Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes. ACS Med Chem Lett 2013; 4:790-4. [PMID: 24900747 DOI: 10.1021/ml400186z] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2013] [Accepted: 06/16/2013] [Indexed: 01/07/2023] Open
Abstract
GPR142 is a G protein-coupled receptor that is predominantly expressed in pancreatic β-cells. GPR142 agonists stimulate insulin secretion in the presence of high glucose concentration, so that they could be novel insulin secretagogues with reduced or no risk of hypoglycemia. We report here the optimization of HTS hit compound 1 toward a proof of concept compound 33, which showed potent glucose lowering effects during an oral glucose tolerance test in mice and monkeys.
Collapse
Affiliation(s)
- Narihiro Toda
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| | - Xiaolin Hao
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Yasuyuki Ogawa
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| | - Kozo Oda
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| | - Ming Yu
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Zice Fu
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Yi Chen
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Yongjae Kim
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Mike Lizarzaburu
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Sarah Lively
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Shauna Lawlis
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Michiko Murakoshi
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| | - Futoshi Nara
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| | - Nobuaki Watanabe
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| | - Jeff D. Reagan
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Hui Tian
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Angela Fu
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Alykhan Motani
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Qingxiang Liu
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Yi-Jyun Lin
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Run Zhuang
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Yumei Xiong
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Peter Fan
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Julio Medina
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Leping Li
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco,
California 94080,
United States
| | - Masanori Izumi
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| | - Ryo Okuyama
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| | - Satoshi Shibuya
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,
Japan
| |
Collapse
|